As a model system to assess the effect of p53 on protein synthesis, we made use of the human colorectal cancer cell line HCT116 and a mutant counterpart, HCT116-TP53−/−, carrying a genomic deletion in the TP53 gene generated by the Vogelstein lab [30]. This evidence concerns the gene TP53 and colorectal cancer.